Clinical trial

Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC)

NCT00912392

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-05-01

PhasePHASE2

Study timeline

Study start (unknown)2009-05-01Date precision: month

Registry last updated2014-09-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Small Cell Lung Cancerunresolved

Interventions

EndostarDRUG

Etoposide-CarboplatinDRUG

Sponsors & collaborators

Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltdlead sponsor

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00912392 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.